Graticule Asia Macro Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History

Graticule Asia Macro Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $985,249 - $1.18 Million	-25,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $467,638 - $711,168	-10,790 Reduced 30.15%	25,000 $1.11 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $833,907 - $2.13 Million	35,790 New	35,790 $1.96 Million

204

92.9M

341K

107K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.51B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Graticule Asia Macro Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Graticule Asia Macro Advisors LLC with notifications on news.